Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions: Complete Statistical AnalysisIndependent statistical analysis of Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00621309).
- Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery: primary endpoint results, effect estimate with confidence interval,…
- Sulindac and Breast Density in Women at Risk of Developing Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sulindac and Breast Density in Women at Risk of Developing Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SUMMITIndependent statistical analysis of A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SUMMIT-LTSIndependent statistical analysis of Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SUN 1120Independent statistical analysis of Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SUN1058Independent statistical analysis of A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone: primary endpoint results, effect estimate with confidence interval,…
- Sunitinib and Capecitabine for First Line Colon Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib and Capecitabine for First Line Colon Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00961571).
- Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Sunitinib in Never-Smokers With Lung Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Never-Smokers With Lung Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01829217).
- Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC): Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib Malate in Refractory Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Refractory Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00912912).
- Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC): Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Sunitinib Non Small Cell Lung Cancer Patients Over 70: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Non Small Cell Lung Cancer Patients Over 70: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00864721).
- Sunitinib to Treat Recurrent Brain Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib to Treat Recurrent Brain Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00923117).
- SUNLIGHTIndependent statistical analysis of Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SUNRAYIndependent statistical analysis of A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SUNRISEIndependent statistical analysis of Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunshine 2 Study for Women With Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Sunshine 2 Study for Women With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01904032).
- superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology: Complete Statistical AnalysisIndependent statistical analysis of superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03585959).
- Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: Complete Statistical AnalysisIndependent statistical analysis of Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01499953).
- Superior Hypogastric Blockade for Postoperative Pain: Complete Statistical AnalysisIndependent statistical analysis of Superior Hypogastric Blockade for Postoperative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03428152).
- Superior Venous Access, Midline vs Ultrasound IVs: Complete Statistical AnalysisIndependent statistical analysis of Superior Venous Access, Midline vs Ultrasound IVs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03440944).
- SuperShelfIndependent statistical analysis of A Multilevel Intervention in the Hunger Relief Network to Improve Diet Among Adults Experiencing Food Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Supplemental Oxygen in Pulmonary Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Supplemental Oxygen in Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01961362).
- Supplementation With Cholecalciferol in Dialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Supplementation With Cholecalciferol in Dialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01974245).
- SUPPORTIndependent statistical analysis of A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Support2QuitIndependent statistical analysis of A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05797155).
- Supported Employment in Patient Aligned Care Teams: Complete Statistical AnalysisIndependent statistical analysis of Supported Employment in Patient Aligned Care Teams: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02400736).
- Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi: Complete Statistical AnalysisIndependent statistical analysis of Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SUPPRESSIndependent statistical analysis of Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01352416).
- Suppression of HIV 1 RNA in People Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Suppression of HIV 1 RNA in People Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02363387).
- SuPRA: Using Wearable Activity Trackers With a New Application to Improve Physical Activity in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of SuPRA: Using Wearable Activity Trackers With a New Application to Improve Physical Activity in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm: Complete Statistical AnalysisIndependent statistical analysis of Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00739401).